San Diego, CA -- (SBWIRE) -- 06/09/2023 -- Rain Oncology Inc. is under investigation over potential securities laws violations in connection with certain financial statements.

Investors who purchased shares of Rain Oncology Inc. (NASDAQ: RAIN), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Rain Oncology Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Newark, CA based Rain Oncology Inc., a late-stage precision oncology company, engages in developing therapies that target oncogenic drivers to genetically select patients in the United States. On May 22, 2023 Rain Oncology Inc. announced its topline results from its Phase 3 MANTRA trial of milademetan. The Company's press release stated, "the trial, evaluating the efficacy, safety, and tolerability of milademetan in patients with dedifferentiated (DD) liposarcoma (LPS), did not meet its primary endpoint of progression free survival (PFS) by blinded independent central review compared to the standard of care, trabectedin" and stated that "[b]ased upon these topline data, Rain does not expect to pursue further development of milademetan in DD LPS."

Shares of Rain Oncology Inc. (NASDAQ: RAIN) declined from $10.51 per share on May 19, 2023, to as low as $0.94 per share on May 30, 2023.

Those who purchased shares of Rain Oncology Inc. (NASDAQ: RAIN) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.